Sai Parenteral's
SAIPARENT •NSE

Sai Parenteral's

₹529.3026.80 (5.33%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
500.05
Today’s high
539.95
52 week low
400.00
52 week high
706.00
Open price
500.05
Previous close
502.50
Live volume
3,52,158
Lower circuit
402.00
Upper circuit
603.00

Fundamentals

Market Cap
₹2,221Cr
ROE
2.91%
P/E Ratio(TTM)
106.95
EPS(TTM)
4.70
P/B Ratio
4.52
Dividend Yield
0.00%
Industry P/E
38.06
Book Value
111.09
Debt to Equity
0.68
Face Value
5

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹182Cr
-9.16%
₹7.92Cr
-39.82%
-75075150225
Jun '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
3Y CAGR+59%
Profit growthValue
3Y CAGR+48%

About

Sai Parenterals is a diversified pharmaceutical formulations company. While it started as a specialist in "parenterals" (injectables), it has evolved into a multi-dosage platform. Its business is split into two main verticals:Branded Generic Formulations and CDMO (Contract Development and Manufacturing). The company covers high-growth therapeutic areas such as cardiovascular, anti-diabetic, neuropsychiatry, and oncology. It operates five manufacturing facilities—four in Hyderabad (Telangana) and one in Ongole (Andhra Pradesh).;
CEO/MD
Anil Kumar Karusala
Founded in
2001
NSE symbol
SAIPARENT

Shareholding pattern

Sep '25
Mar '26
Apr '26
Jun '26
Shareholder details

Mutual Funds Invested (2)

Livesquawk •
SAI Parenterals' Q1 EBITDA surged to ₹235M from ₹47M YoY. Q1 EBITDA margin declined to 13.2% from 14.2% YoY.
2026
11
Aug
Quarterly Result
Release date
23
May
Quarterly & Annual Result
Release date
Events calendar
View upcoming events in other stocks